Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sari T Pitkänen, Matti K Salo & Markku Heikinheimo. (2000) Hereditary tyrosinaemia type I: from basics to progress in treatment. Annals of Medicine 32:8, pages 530-538.
Read now
Read now
M. E. Martínez, M. T. Del Campo, M. A. Plaza, A. Torrijos & J. Gijón. (1997) Pamidronate and biochemical markers of bone turnover. Scandinavian Journal of Clinical and Laboratory Investigation 57:7, pages 581-586.
Read now
Read now
Articles from other publishers (26)
Ran Namgung & Reginald C. Tsang. 2017. Fetal and Neonatal Physiology. Fetal and Neonatal Physiology
296
312.e3
.
R.a.n. Namgung & Reginald C. Tsang. 2011. Fetal and Neonatal Physiology. Fetal and Neonatal Physiology
384
403
.
Martin N. Montoro & T. Murphy Goodwin. 2010. de Swiet's Medical Disorders in Obstetric Practice. de Swiet's Medical Disorders in Obstetric Practice
352
370
.
Diran Herebian, Ute Spiekerkötter, Marc Lamshöft, Eva Thimm, Maurice Laryea & Ertan Mayatepek. (2009) Liquid chromatography tandem mass spectrometry method for the quantitation of NTBC (2-(nitro-4-trifluoromethylbenzoyl)1,3-cyclohexanedione) in plasma of tyrosinemia type 1 patients. Journal of Chromatography B 877:14-15, pages 1453-1459.
Crossref
Crossref
Patti J. ThureenOussama Itani & Reginald Tsang. 2009. Neonatal Nutrition and Metabolism. Neonatal Nutrition and Metabolism
185
228
.
Merja Ashorn, Sari Pitk??nen, Matti K Salo & Markku Heikinheimo. (2006) Current Strategies for the Treatment of Hereditary Tyrosinemia Type I. Pediatric Drugs 8:1, pages 47-54.
Crossref
Crossref
Erwin Kuntz. 2006. Hepatology Principles and Practice. Hepatology Principles and Practice
577
635
.
Deepali Karnik, Niranjan Thomas, C. E. Eapen, A. K. Jana & A. Oommen. (2004) Tyrosinemia type I: A clinico-laboratory case report. The Indian Journal of Pediatrics 71:10, pages 929-932.
Crossref
Crossref
Ran Namgung & Reginald C. Tsang. 2004. Fetal and Neonatal Physiology. Fetal and Neonatal Physiology
323
341
.
Angela Evans. (2016) An Infant with Otitis Media and Abdominal Distension. Clinical Pediatrics 41:7, pages 537-541.
Crossref
Crossref
Erwin Kuntz & Hans-Dieter KuntzErwin Kuntz & Hans-Dieter Kuntz. 2002. Hepatology. Hepatology
519
574
.
Barry N. J. Walters & Michael de Swiet. 2002. Medical Disorders in Obstetric Practice. Medical Disorders in Obstetric Practice
459
485
.
Jennifer L. Aponte, Gary A. Sega, Loren J. Hauser, Madhu S. Dhar, Catherine M. Withrow, Donald A. Carpenter, Eugene M. Rinchik, Cymbeline T. Culiat & Dabney K. Johnson. (2001) Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1. Proceedings of the National Academy of Sciences 98:2, pages 641-645.
Crossref
Crossref
Raynard L. Bateman, P. Bhanumoorthy, John F. Witte, Ronald W. McClard, Markus Grompe & David E. Timm. (2001) Mechanistic Inferences from the Crystal Structure of Fumarylacetoacetate Hydrolase with a Bound Phosphorus-based Inhibitor. Journal of Biological Chemistry 276:18, pages 15284-15291.
Crossref
Crossref
Maryse St-Louis & Robert M. Tanguay. (1997) Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: Overview. Human Mutation 9:4, pages 291-299.
Crossref
Crossref
Josée Dubois, Laurent Garel, Heidi Patriquin, Khazal Paradis, Sylviane Forget, Denis Filiatrault, Andrée Grignon, Pierre Russo & Dickens St-Vil. (1996) Imaging features of type 1 hereditary tyrosinemia: a review of 30 patients. Pediatric Radiology 26:12, pages 845-851.
Crossref
Crossref
JACQUES POUDRIER, MARYSE ST-LOUIS, FRANCINE LETTRE, KARINE GIBSON, CLAUDE PRÉVOST, JEAN LAROCHELLE & ROBERT M. TANGUAY. (1996) FREQUENCY OF THE IVS12+5G→A SPLICE MUTATION OF THE FUMARYLACETOACETATE HYDROLASE GENE IN CARRIERS OF HEREDITARY TYROSINAEMIA IN THE FRENCH CANADIAN POPULATION OF SAGUENAY-LAC-ST-JEAN. Prenatal Diagnosis 16:1, pages 59-64.
Crossref
Crossref
Markus Grompe, Sven Lindstedt, Muhsen Al-Dhalimy, Nancy G. Kennaway, John Papaconstantinou, Carlos A. Torres-Ramos, Ching-Nau Ou & Milton Finegold. (1995) Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. Nature Genetics 10:4, pages 453-460.
Crossref
Crossref
René Romero & Joel E. Lavine. (1995) Walking the ethical highwire: Genetic screening and hereditary tyrosinemia. Hepatology 21:4, pages 1193-1195.
Crossref
Crossref
Bernadette C. Holdner & Terry Magnuson. (1994) A mouse model for human hereditary tyrosinemia I. BioEssays 16:2, pages 85-87.
Crossref
Crossref
Michael de Swiet & John Lynn. 1993. Surgical Endocrinology. Surgical Endocrinology
85
92
.
S Ruppert, G Kelsey, A Schedl, E Schmid, E Thies & G Schütz. (1992) Deficiency of an enzyme of tyrosine metabolism underlies altered gene expression in newborn liver of lethal albino mice.. Genes & Development 6:8, pages 1430-1443.
Crossref
Crossref
A Salt, ND Barnes, K Rolles, RY Calne, PT Clayton & JV Leonard. (1992) Liver transplantation in tyrosinaemia type 1: the dilemma of timing the operation. Acta Paediatrica 81:5, pages 449-452.
Crossref
Crossref
Pinar T. Ozand & Generoso G. Gascon. (2016) Topical Review Article: Organic Acidurias: A Review. Part 1. Journal of Child Neurology 6:3, pages 196-219.
Crossref
Crossref
Robert E. Lynch. (1990) Ionized Calcium: Pediatric Perspective. Pediatric Clinics of North America 37:2, pages 373-389.
Crossref
Crossref
Barry NJ Walters. (2008) Calcium metabolism in pregnancy. Fetal and Maternal Medicine Review 1:2, pages 213-222.
Crossref
Crossref